IP Verse

Glaxosmithkline Biologicals competitive analysis

Latest oppositions filed by Glaxosmithkline Biologicals

Explore patent oppositions filed by Glaxosmithkline Biologicals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNAFeb 17, 2023
EP3682905
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 26, 2022
EP2970456
Methods And Compositions For Delivering Mrna Coded AntibodiesSHIRE HUMAN GENETIC THERAPIESFeb 18, 2022
EP3431485
Engineered Nucleic Acids And Methods Of Use ThereofMODERNASep 30, 2021
EP3489211
Improved Methods For Preparing SqualeneNOVARTISApr 15, 2021
EP3336082
Cleavable LipidsTRANSLATE BIOJan 15, 2021
EP2614835
Vaccination With Multiple Clades Of H5 Influenza A VirusNOVARTISMay 20, 2020
EP3103784
Manufacture Of An Oil-In-Water Emulsion Comprising SqualeneNOVARTISNov 6, 2019
EP2968112
Stable Aqueous Formulations Of Adenovirus VectorsARECORMay 23, 2018
EP2558116
Agent For Locally Treating Cervical DysplasiasCHARIT UNIVERSITTSMEDIZIN BERLINDec 21, 2017

Latest patents of Glaxosmithkline Biologicals opposed by its competitors

Explore Glaxosmithkline Biologicals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 25, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3527224
Feb 26, 2025Rsv Immunization Regimen1
EP4144368
Feb 26, 2025Rsv Immunization Regimen1
EP4226941
Oct 23, 2024Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna6
EP3480209
Nov 29, 2023Expression System1
EP3564378
Nov 1, 2023Immunogenic Composition1
EP4066819
Mar 1, 2023Small Liposomes For Delivery Of Immunogen-Encoding Rna4
EP4043040
Jan 11, 2023Small Liposomes For Delivery Of Immunogen-Encoding Rna5
EP4008357
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding Rna5
EP4066855
Dec 28, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
EP4066857
Dec 21, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4

Latest PTAB cases involving Glaxosmithkline Biologicals

Discover the latest PTAB cases involving Glaxosmithkline Biologicals, highlighting their recent legal challenges and patent disputes.

Last updated on: Jun 29, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Glaxosmithkline Biologicals

IPR2020-00962May 27, 2020GLAXOSMITHKLINE BIOLOGICALSPFENEXTerminated-Settled
IPR2020-00890May 7, 2020GLAXOSMITHKLINE BIOLOGICALSPFENEXTerminated
IPR2019-01478Aug 9, 2019PFENEXGLAXOSMITHKLINE BIOLOGICALSInstitution Denied
IPR2019-01027May 6, 2019PFENEXGLAXOSMITHKLINE BIOLOGICALSInstitution Denied
IPR2019-01028May 6, 2019PFENEXGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled
IPR2019-00230Nov 7, 2018MERCK SHARP & DOHMEGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled
IPR2019-00241Nov 7, 2018MERCK SHARP & DOHMEGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled
IPR2018-01229Jun 11, 2018MERCK SHARP & DOHMEGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled
IPR2018-01234Jun 11, 2018MERCK SHARP & DOHMEGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled
IPR2018-01236Jun 11, 2018MERCK SHARP & DOHMEGLAXOSMITHKLINE BIOLOGICALSTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Biologicals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE2912863
PFIZER541154412
SANOFI6229 - -
WEICKMANN & WEICKMANN56 - - -